Clinical trial
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence ('ART-CARMA')
NCT05301673 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence ('ART-CARMA')
- Lead sponsor
- King's College London
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 12, 2022
- Completion date
- March 31, 2025
- Enrollment
- 600 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder, cardiovascular diseases, medication adherence